Haddadin Yezan Munther

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Haddadin Yezan Munther's trades of Outlook Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
B Purchase
28,801 +5.1%
16.85
US$1,519,943 		28,801 +5.1% 16.85 US$1,519,943
2026-05-27 2026-05-26
B Purchase
96,257 +9.1%
475.56
US$3,032,781 		96,257 +9.1% 475.56 US$3,032,781
2024-03-29 2024-03-28
B Purchase
90,788 +44.7%
324.63
US$3,434,744 		90,788 +44.7% 324.63 US$3,434,744
2022-10-11 2022-10-07
B Purchase
3,600 +6.0%
1.27
US$4,572 		3,600 +6.0% 1.27 US$4,572
2022-10-11 2022-10-06
B Purchase
29,743 +99.1%
1.29
US$38,368 		29,743 +99.1% 1.29 US$38,368
2021-12-02 2021-12-02
B Purchase
10,000 +50.0%
1.39
US$13,900 		10,000 +50.0% 1.39 US$13,900
2021-04-20 2021-04-19
B Purchase
10,000 +100.0%
1.82
US$18,200 		10,000 +100.0% 1.82 US$18,200
2020-09-22 2020-09-22
B Purchase
10,000 +inf%
0.72
US$7,245 		10,000 +inf% 0.72 US$7,245